These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29329977)

  • 1. Recent insights in the use of nanocarriers for the oral delivery of bioactive proteins and peptides.
    Batista P; Castro PM; Madureira AR; Sarmento B; Pintado M
    Peptides; 2018 Mar; 101():112-123. PubMed ID: 29329977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art.
    Moutinho CG; Matos CM; Teixeira JA; Balcão VM
    J Drug Target; 2012 Feb; 20(2):114-41. PubMed ID: 22023555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in topical delivery of proteins and peptides mediated by soft matter nanocarriers.
    Witting M; Obst K; Friess W; Hedtrich S
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1355-69. PubMed ID: 25687276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of PLGA nanoparticles with mucoadhesive guar-gum films for buccal delivery of antihypertensive peptide.
    Castro PM; Baptista P; Madureira AR; Sarmento B; Pintado ME
    Int J Pharm; 2018 Aug; 547(1-2):593-601. PubMed ID: 29800740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems.
    Soares AF; Carvalho Rde A; Veiga F
    Nanomedicine (Lond); 2007 Apr; 2(2):183-202. PubMed ID: 17716120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
    Dilnawaz F
    Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of semi-synthetic biopolymer complexes: modified polysaccharide nano-carriers for enhancement of oral drug bioavailability.
    Sithole MN; Choonara YE; du Toit LC; Kumar P; Pillay V
    Pharm Dev Technol; 2017 Mar; 22(2):283-295. PubMed ID: 27470222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid polymer hybrid as emerging tool in nanocarriers for oral drug delivery.
    Hallan SS; Kaur P; Kaur V; Mishra N; Vaidya B
    Artif Cells Nanomed Biotechnol; 2016; 44(1):334-49. PubMed ID: 25237838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Active Targeting of Drugs and Bioactive Molecules via Oral Administration by Ligand-Conjugated Lipidic Nanocarriers: Recent Advances.
    Shreya AB; Raut SY; Managuli RS; Udupa N; Mutalik S
    AAPS PharmSciTech; 2018 Dec; 20(1):15. PubMed ID: 30564942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of Oral Bioavailability of Protein and Peptide by Polysaccharide-based Nanoparticles.
    Islam MM; Raikwar S
    Protein Pept Lett; 2024; 31(3):209-228. PubMed ID: 38509673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral films as breakthrough tools for oral delivery of proteins/peptides.
    Castro PM; Fonte P; Sousa F; Madureira AR; Sarmento B; Pintado ME
    J Control Release; 2015 Aug; 211():63-73. PubMed ID: 25979328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymer-based nanoparticles for oral insulin delivery: Revisited approaches.
    Fonte P; Araújo F; Silva C; Pereira C; Reis S; Santos HA; Sarmento B
    Biotechnol Adv; 2015 Nov; 33(6 Pt 3):1342-54. PubMed ID: 25728065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advance of DNA and CCPs-based nanocarriers in drug delivery systems.
    Wu Y; Yao X; Chen Y; Li Y; Tian W
    Biomed Mater Eng; 2017; 28(s1):S255-S261. PubMed ID: 28372302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymeric particulate technologies for oral drug delivery and targeting: a pathophysiological perspective.
    Hunter AC; Elsom J; Wibroe PP; Moghimi SM
    Nanomedicine; 2012 Sep; 8 Suppl 1():S5-20. PubMed ID: 22846372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicity evaluation of nanocarriers for the oral delivery of macromolecular drugs.
    Ojer P; Iglesias T; Azqueta A; Irache JM; López de Cerain A
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):206-17. PubMed ID: 26493712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.
    Kahraman E; Güngör S; Özsoy Y
    Ther Deliv; 2017 Nov; 8(11):967-985. PubMed ID: 29061106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-based nanocarriers for oral peptide delivery.
    Niu Z; Conejos-Sánchez I; Griffin BT; O'Driscoll CM; Alonso MJ
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt B):337-354. PubMed ID: 27080735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-assembly of peptide amphiphiles for drug delivery: the role of peptide primary and secondary structures.
    Song Z; Chen X; You X; Huang K; Dhinakar A; Gu Z; Wu J
    Biomater Sci; 2017 Nov; 5(12):2369-2380. PubMed ID: 29051950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies.
    Galindo-Rodriguez SA; Allemann E; Fessi H; Doelker E
    Crit Rev Ther Drug Carrier Syst; 2005; 22(5):419-64. PubMed ID: 16313233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress and prospects of polysaccharide-based nanocarriers for oral delivery of proteins/peptides.
    Yuan H; Guo C; Liu L; Zhao L; Zhang Y; Yin T; He H; Gou J; Pan B; Tang X
    Carbohydr Polym; 2023 Jul; 312():120838. PubMed ID: 37059563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.